Impact Factor: 4.1
Citescore: 6.6
All metrics >>
Highlighted Articles
Online First
Original research:
Effects of a combined exercise and dietary intervention on clinical outcomes in patients with ovarian cancer: the Physical Activity and Dietary intervention in OVArian cancer (PADOVA) randomized controlled trial7 September 2024
Original research:
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study7 September 2024
Video article:
Oncovascular surgery in gynecologic oncology: en bloc metastatic lymph node and infiltrated inferior vena cava resection followed by patch reconstruction7 September 2024
Original research:
Novel scoring system incorporating lipoproteins to predict outcomes of epithelial ovarian cancer patients7 September 2024
Most Read Articles
Original research:
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*1 May 2023
Original research:
Endometrial cancer after endometrial ablation: a systematic review5 December 2022
Consensus statement:
Low-grade serous ovarian cancer: expert consensus report on the state of the science12 February 2024
Current Issue
Original research:
SENECA study: staging endometrial cancer based on molecular classification2 September 2024
Editorial:
Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping2 September 2024
Review:
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 20242 September 2024
Consensus statement:
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom2 September 2024
Original research:
Risk factors for vaginal squamous intra-epithelial lesions in women with high-grade cervical lesions2 September 2024
IJGC Zoom Journal Club
Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial
Join Editor in Chief Pedro Ramirez, David Viveros, René Pareja, and the IJGC Editorial Fellows in a lively and entertaining discussion over Zoom of the lead article in IJGC's August 2024 issue.
Find out more